<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Monoclonal-Antibodies on 生物经济</title><link>https://cn.bioecon.ru/technologies/monoclonal-antibodies/</link><description>Recent content in Monoclonal-Antibodies on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Sat, 11 Jul 2026 14:19:14 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/technologies/monoclonal-antibodies/index.xml" rel="self" type="application/rss+xml"/><item><title>生物药 (Biologics)</title><link>https://cn.bioecon.ru/technology/biologics/</link><pubDate>Thu, 18 Jun 2026 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/biologics/</guid><description>生物药——单抗、ADC、CAR-T 和基因疗法——是规模最大、增长最快的药物类别，建立在可复制的细胞系平台上，滴度 2–10 g/L。</description></item><item><title>抗体偶联药物（ADC）</title><link>https://cn.bioecon.ru/technology/antibody-drug-conjugates-adcs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/antibody-drug-conjugates-adcs/</guid><description>利用单克隆抗体将高效细胞毒性载荷直接递送至癌细胞的靶向肿瘤疗法，最大限度地降低全身毒性。</description></item></channel></rss>